Advances in cancer treatment have led to increased survival rates among women diagnosed with cancer. However, many cancer ...
The University of Pennsylvania has taken a novel approach to ensure that women with suspicious adnexal lesions are referred ...
As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute ...
Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer ...
Mrs. Rao, a health-conscious 55-year-old, was diagnosed with a large ovarian mass after experiencing persistent abdominal ...
Colon cancer, also known as colorectal cancer, is a type of cancer that begins in the large intestine (colon) or the rectum.
A fundamental shake-up of how we screen women for breast cancer could save more lives from the disease. Here are some options ...
On Monday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a key patent application covering Anixa Biosciences, Inc.’s (NASDAQ:ANIX) ovarian cancer vaccine ...
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
In today's Morning Rounds newsletter, proposed cuts to cancer research under the Trump administration, a fake CDC page with ...
AbbVie claims that Genmab divulged key trade secrets to support the development of ProfoundBio’s investigational ...
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback